Mary A. Whooley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mary A. Whooley has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Warren S. Browner
5 shared publicationsNelson B. Schiller
4 shared publicationsHaiying Liu
3 shared publications- Jane A. Cauley
Department of Epidemiology, School of Public Health, University of Pittsburgh , Pittsburgh, PA 15261
3 shared publications Barry Massie
2 shared publicationsKirsten Bibbins-Domingo
Department of Medicine, University of California, San Francisco, USA
2 shared publications
Latest Publications
- 1 February 2005
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (3) , 332-336
Association of anemia with diastolic dysfunction among patients with coronary artery disease in the Heart and Soul Study
- 1 February 2005
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (3) , 332-336
Association of anemia with diastolic dysfunction among patients with coronary artery disease in the Heart and Soul Study
- 1 August 2004
- Published by Elsevier in Biological Psychiatry
- Vol. 56 (4) , 241-247
Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study
- 1 August 2004
- Published by Elsevier in Biological Psychiatry
- Vol. 56 (4) , 241-247
Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study
- 1 June 2004
- Published by SAGE Publications in Journal of Geriatric Psychiatry and Neurology
- Vol. 17 (2) , 88-92
Depressive Symptoms and Bone Mineral Density in Older Men
Most studies examining the relation between depression and bone mineral density (BMD) have been limited to psychiatric patients or to community-dwelling, older women. We conducted a cross-sectional and prospective cohort study to determine whether depressive symptoms are associated with low BMD in community-dwelling, older men. We recruited 515 men 50 years of age or older from population-based listings of age-eligible men. Participants completed the Geriatric Depression Scale (short form) and were considered depressed if they scored 6 or more out of 15 possible points. BMD was measured in the spine and hip using dual energy x-ray absorptiometry in all participants, and again an average of 3.6 years later in a random subset of 100 participants. The prevalence of depressive symptoms (GDS = 6) was 3.1% (16 of 515). We found no difference in mean BMD or mean percent change in BMD per year of the hip and lumbar spine in men who had 6 or more depressive symptoms compared with men who reported 5 or fewer symptoms of depression. These findings suggest that depressive symptoms are not associated with BMD in community-dwelling, older men.
- 1 June 2004
- Published by SAGE Publications in Journal of Geriatric Psychiatry and Neurology
- Vol. 17 (2) , 88-92
Depressive Symptoms and Bone Mineral Density in Older Men
Most studies examining the relation between depression and bone mineral density (BMD) have been limited to psychiatric patients or to community-dwelling, older women. We conducted a cross-sectional and prospective cohort study to determine whether depressive symptoms are associated with low BMD in community-dwelling, older men. We recruited 515 men 50 years of age or older from population-based listings of age-eligible men. Participants completed the Geriatric Depression Scale (short form) and were considered depressed if they scored 6 or more out of 15 possible points. BMD was measured in the spine and hip using dual energy x-ray absorptiometry in all participants, and again an average of 3.6 years later in a random subset of 100 participants. The prevalence of depressive symptoms (GDS = 6) was 3.1% (16 of 515). We found no difference in mean BMD or mean percent change in BMD per year of the hip and lumbar spine in men who had 6 or more depressive symptoms compared with men who reported 5 or fewer symptoms of depression. These findings suggest that depressive symptoms are not associated with BMD in community-dwelling, older men.
- 1 April 2004
- Published by Elsevier in The American Journal of Medicine
- Vol. 116 (8) , 509-516
Is b-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? data from the heart and soul study
- 1 April 2004
- Published by Elsevier in The American Journal of Medicine
- Vol. 116 (8) , 509-516
Is b-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? data from the heart and soul study
- 16 December 2003
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (24) , 2987-2992
B-Type Natriuretic Peptide and Ischemia in Patients With Stable Coronary Disease
Background— In patients with symptoms of heart failure, elevations in B-type natriuretic peptide (BNP) accurately identify ventricular dysfunction. However, BNP levels are not specific for ventricular dysfunction in patients who do not have overt symptoms of heart failure, suggesting that other cardiac processes such as myocardial ischemia may also cause elevations in BNP. Methods and Results— To determine whether BNP elevations are associated with myocardial ischemia, we measured plasma BNP levels before performing exercise treadmill testing with stress echocardiography in outpatients with stable coronary disease. Of the 355 participants, 113 (32%) had inducible ischemia. Compared with participants in the lowest BNP quartile (0 to 16.4 pg/mL), those in the highest quartile of BNP (≥105 pg/mL) had double the risk of inducible ischemia (adjusted relative risk, 2.0; 95% CI, 1.2 to 2.6; P =0.008). The relation between elevated BNP levels and inducible ischemia was especially evident in the 206 participants who had a history of myocardial infarction (adjusted relative risk, 2.6; 95% CI, 1.5 to 3.7, P =0.002) and was absent in those without a history of myocardial infarction (adjusted relative risk, 1.0; 95% CI, 0.3 to 2.2; P =0.9). This association between BNP levels and inducible ischemia remained strong after adjustment for measures of systolic and diastolic dysfunction. Conclusions— Elevated levels of BNP are independently associated with inducible ischemia among outpatients with stable coronary disease, particularly among those with a history of myocardial infarction. The observed association between BNP levels and ischemia may explain why tests for BNP are not specific for ventricular dysfunction among patients with coronary disease.
- 16 December 2003
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (24) , 2987-2992
B-Type Natriuretic Peptide and Ischemia in Patients With Stable Coronary Disease
Background— In patients with symptoms of heart failure, elevations in B-type natriuretic peptide (BNP) accurately identify ventricular dysfunction. However, BNP levels are not specific for ventricular dysfunction in patients who do not have overt symptoms of heart failure, suggesting that other cardiac processes such as myocardial ischemia may also cause elevations in BNP. Methods and Results— To determine whether BNP elevations are associated with myocardial ischemia, we measured plasma BNP levels before performing exercise treadmill testing with stress echocardiography in outpatients with stable coronary disease. Of the 355 participants, 113 (32%) had inducible ischemia. Compared with participants in the lowest BNP quartile (0 to 16.4 pg/mL), those in the highest quartile of BNP (≥105 pg/mL) had double the risk of inducible ischemia (adjusted relative risk, 2.0; 95% CI, 1.2 to 2.6; P =0.008). The relation between elevated BNP levels and inducible ischemia was especially evident in the 206 participants who had a history of myocardial infarction (adjusted relative risk, 2.6; 95% CI, 1.5 to 3.7, P =0.002) and was absent in those without a history of myocardial infarction (adjusted relative risk, 1.0; 95% CI, 0.3 to 2.2; P =0.9). This association between BNP levels and inducible ischemia remained strong after adjustment for measures of systolic and diastolic dysfunction. Conclusions— Elevated levels of BNP are independently associated with inducible ischemia among outpatients with stable coronary disease, particularly among those with a history of myocardial infarction. The observed association between BNP levels and ischemia may explain why tests for BNP are not specific for ventricular dysfunction among patients with coronary disease.
- 1 September 2003
- Published by Elsevier in The American Journal of Cardiology
- Vol. 92 (6) , 705-707
Relation of self-reported angina pectoris to inducible myocardial ischemia in patients with known coronary artery disease: The Heart and Soul Study
- 1 September 2003
- Published by Elsevier in The American Journal of Cardiology
- Vol. 92 (6) , 705-707
Relation of self-reported angina pectoris to inducible myocardial ischemia in patients with known coronary artery disease: The Heart and Soul Study
- Top Cited PapersOpen Access
- 9 July 2003
- Published by American Medical Association (AMA) in JAMA
- Vol. 290 (2) , 215-221
Depressive Symptoms and Health-Related Quality of Life
A primary goal of therapy for patients with chronic disease is to improve their health status, including symptoms, functional status, and quality of life. In patients with coronary disease, cardiovascular interventions are known to improve health status,1-4 but the extent to which such benefits result from changes in cardiac vs noncardiac factors is unclear. Most studies have found only limited associations between cardiac function and health status measures,5-9 suggesting that other factors may be as important as cardiac function in determining the health status of patients with heart disease.
- 9 July 2003
- Published by American Medical Association (AMA) in JAMA
- Vol. 290 (2) , 215-221
Top Cited PapersOpen AccessDepressive Symptoms and Health-Related Quality of Life
A primary goal of therapy for patients with chronic disease is to improve their health status, including symptoms, functional status, and quality of life. In patients with coronary disease, cardiovascular interventions are known to improve health status,1-4 but the extent to which such benefits result from changes in cardiac vs noncardiac factors is unclear. Most studies have found only limited associations between cardiac function and health status measures,5-9 suggesting that other factors may be as important as cardiac function in determining the health status of patients with heart disease.
- 21 January 2003
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (2) , 245-250
C-Reactive Protein and Ischemia in Users and Nonusers of β-Blockers and Statins
Background— Elevated levels of C-reactive protein (CRP) are associated with an increased risk of coronary events, but whether inflammation is associated with inducible ischemia in patients with stable coronary disease is unknown. Methods and Results— We recruited patients with known coronary disease from 2 VA Medical Centers and 1 University-based medical center for the Heart and Soul Study. We measured CRP levels in 118 participants who had exercise-induced ischemia and in 111 who did not have inducible ischemia, as determined by stress echocardiography. We used logistic regression to examine the risk of exercise-induced ischemia associated with elevated CRP. We found that 75% (39/52) of participants in the highest CRP category (>0.38 mg/dL) had inducible ischemia, compared with 45% (79/177) in the lower 4 categories combined (adjusted odds ratio 4.2; 95% confidence interval 1.6 to 11; P =0.004). However, this association differed in users and nonusers of β-blockers and statins. Among 89 participants who did not use β-blockers, 93% in the highest CRP category had exercise-induced ischemia, compared with 42% in the lower 4 categories ( P =0.03). Among 67 participants who did not use statins, 94% in the highest CRP category had exercise-induced ischemia, compared with 44% in the lower 4 categories ( P =0.009). We did not observe a significant association between CRP and ischemia among participants who were treated with either of these medications. Conclusion— Elevated CRP levels are associated with inducible ischemia in patients with stable coronary disease, particularly among those not treated with β-blockers or statins.
- 21 January 2003
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (2) , 245-250
C-Reactive Protein and Ischemia in Users and Nonusers of β-Blockers and Statins
Background— Elevated levels of C-reactive protein (CRP) are associated with an increased risk of coronary events, but whether inflammation is associated with inducible ischemia in patients with stable coronary disease is unknown. Methods and Results— We recruited patients with known coronary disease from 2 VA Medical Centers and 1 University-based medical center for the Heart and Soul Study. We measured CRP levels in 118 participants who had exercise-induced ischemia and in 111 who did not have inducible ischemia, as determined by stress echocardiography. We used logistic regression to examine the risk of exercise-induced ischemia associated with elevated CRP. We found that 75% (39/52) of participants in the highest CRP category (>0.38 mg/dL) had inducible ischemia, compared with 45% (79/177) in the lower 4 categories combined (adjusted odds ratio 4.2; 95% confidence interval 1.6 to 11; P =0.004). However, this association differed in users and nonusers of β-blockers and statins. Among 89 participants who did not use β-blockers, 93% in the highest CRP category had exercise-induced ischemia, compared with 42% in the lower 4 categories ( P =0.03). Among 67 participants who did not use statins, 94% in the highest CRP category had exercise-induced ischemia, compared with 44% in the lower 4 categories ( P =0.009). We did not observe a significant association between CRP and ischemia among participants who were treated with either of these medications. Conclusion— Elevated CRP levels are associated with inducible ischemia in patients with stable coronary disease, particularly among those not treated with β-blockers or statins.
- 9 December 2002
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 162 (22) , 2614-2620
Depressive Symptoms, Unemployment, and Loss of Income
Research from JAMA Internal Medicine — Depressive Symptoms, Unemployment, and Loss of Income — The CARDIA Study
- 9 December 2002
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 162 (22) , 2614-2620
Depressive Symptoms, Unemployment, and Loss of Income
Research from JAMA Internal Medicine — Depressive Symptoms, Unemployment, and Loss of Income — The CARDIA Study
- Open Access
- 22 July 2002
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 162 (14) , 1604-1610
Religious Involvement and Cigarette Smoking in Young Adults
Research from JAMA Internal Medicine — Religious Involvement and Cigarette Smoking in Young Adults — The CARDIA Study
- 22 July 2002
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 162 (14) , 1604-1610
Open AccessReligious Involvement and Cigarette Smoking in Young Adults
Research from JAMA Internal Medicine — Religious Involvement and Cigarette Smoking in Young Adults — The CARDIA Study